Thymosin alpha-1 studies: 615 papers with results
Page 3 of 13
- Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19.
Lin P · Scientific reports · 2021
Observational study · 1 result
- Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation.
Ji SM · Transplantation proceedings · 2007
Observational study · 6 results
- [Hepatocellular carcinoma with tumor thrombi in the portal vein. A comparison of therapeutic effects by different treatments].
Cheng SQ · Zhonghua zhong liu za zhi [Chinese journal of oncology] · 2005
Observational study · 3 results
- Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching.
Huang C · Frontiers in medicine · 2021
Observational study · 6 results
- Risk Factors and Drug Efficacy for Severe Illness in Hemodialysis Patients Infected with the Omicron Variant of COVID-19.
Wu Y · Kidney & blood pressure research · 2023
Observational study · 1 result
- Thymosin α1 modulated the immune landscape of COVID-19 patients revealed by single-cell RNA and TCR sequencing.
Bai H · International immunopharmacology · 2023
Observational study · 7 results
- Emergence of an S gene mutant during thymosin alpha1 therapy in a patient with chronic hepatitis B.
Tang JH · The Journal of infectious diseases · 1998
Case report or series · 1 result
- Thymosin alpha 1 improves severe acute pancreatitis in rats via regulation of peripheral T cell number and cytokine serum level.
Yao W · Journal of gastroenterology and hepatology · 2007
Animal study (in vivo) · rat · 7 results
- Efficacy of thymosin α1 and interferon α for the treatment of severe acute pancreatitis in a rat model.
Wang X · Molecular medicine reports · 2015
Animal study (in vivo) · rat · 7 results
- Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.
Romani L · Blood · 2004
Animal study (in vivo) · mouse · 7 results
- Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance.
Romani L · Blood · 2006
Animal study (in vivo) · mouse · 6 results
- Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats.
Armutcu F · Clinical biochemistry · 2005
Animal study (in vivo) · rat · 9 results
- Effect of thymosin peptides on the chick chorioallantoic membrane angiogenesis model.
Koutrafouri V · Biochimica et biophysica acta · 2001
Animal study (in vivo) · chick · 1 result
- Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.
Liu K · Cell reports. Medicine · 2024
Animal study (in vivo) · 2 results
- Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo.
Bozza S · International immunology · 2007
Animal study (in vivo) · mouse · 4 results
- In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants.
Liu Q · International journal of pharmaceutics · 2010
Animal study (in vivo) · mouse and rat · 6 results
- Modulation of natural killer activity by thymosin alpha 1 and interferon.
Favalli C · Cancer immunology, immunotherapy : CII · 1985
Animal study (in vivo) · mouse · 2 results
- Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.
Favalli C · International journal of immunopharmacology · 1989
Animal study (in vivo) · mouse · 2 results
- Thymosin alpha 1 down-regulates the growth of human non-small cell lung cancer cells in vitro and in vivo.
Moody TW · Cancer research · 1993
Animal study (in vivo) · mouse · 4 results
- Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.
Xu YG · Applied and environmental microbiology · 2015
Animal study (in vivo) · pig · 2 results
- Reconstitution of T cell functions in aging mice by thymosin alpha 1.
Frasca D · Immunopharmacology · 1986
Animal study (in vivo) · mouse · 4 results
- Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1.
Frasca D · European journal of immunology · 1987
Animal study (in vivo) · mouse · 2 results
- Increase of mouse resistance to Candida albicans infection by thymosin alpha 1.
Bistoni F · Infection and immunity · 1982
Animal study (in vivo) · mouse · 3 results
- Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.
Garaci E · Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy · 1993
Animal study (in vivo) · mouse · 7 results
- Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
Umeda Y · Cancer immunology, immunotherapy : CII · 1983
Animal study (in vivo) · mouse · 5 results
- Thymosin Alpha-1 Inhibits Complete Freund's Adjuvant-Induced Pain and Production of Microglia-Mediated Pro-inflammatory Cytokines in Spinal Cord.
Xu Y · Neuroscience bulletin · 2019
Animal study (in vivo) · 7 results
- Thymosin alpha1 as a chemopreventive agent in lung and breast cancer.
Moody TW · Annals of the New York Academy of Sciences · 2007
Animal study (in vivo) · mouse and rat · 5 results
- Thymosin α1 protects from CTLA-4 intestinal immunopathology.
Renga G · Life science alliance · 2020
Animal study (in vivo) · mouse · 4 results
- Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression.
Ni C · Cancer letters · 2015
Animal study (in vivo) · 7 results
- Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing.
Malinda KM · Journal of immunology (Baltimore, Md. : 1950) · 1998
Animal study (in vivo) · 5 results
- Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
Hadden JW · International journal of immunopharmacology · 1995
Animal study (in vivo) · mouse · 8 results
- Thymosin fraction 5 causes increased serum corticosterone in rodents in vivo.
McGillis JP · Journal of immunology (Baltimore, Md. : 1950) · 1985
Animal study (in vivo) · mouse · 4 results
- Protective activity of thymosin against opportunistic infections in animal models.
Ishitsuka H · Cancer immunology, immunotherapy : CII · 1983
Animal study (in vivo) · mouse · 8 results
- Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.
Papanastasiou M · Cancer immunology, immunotherapy : CII · 1992
Animal study (in vivo) · mouse · 1 result
- Effects of thymosin alpha-1 on pituitary hormone release.
Milenkovic L · Neuroendocrinology · 1992
Animal study (in vivo) · rat · 8 results
- Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.
Shrivastava P · Journal of biomedical science · 2004
Animal study (in vivo) · mouse · 5 results
- Thymosin alpha1 accelerates restoration of T cell-mediated neutralizing antibody response in immunocompromised hosts.
Li CL · International immunopharmacology · 2002
Animal study (in vivo) · mouse · 3 results
- Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice.
Goso C · Clinical and experimental immunology · 1992
Animal study (in vivo) · mouse · 2 results
- Thymosin alpha1 inhibits mammary carcinogenesis in Fisher rats.
Moody TW · Peptides · 2002
Animal study (in vivo) · fisher rat · 3 results
- Evaluation of thymosin α 1 in nonclinical models of the immune-suppressing indications melanoma and sepsis.
King RS · Expert opinion on biological therapy · 2015
Animal study (in vivo) · mouse · 7 results
- Immunopharmacology of thymosin alpha1 and cytokine synergy.
Naylor PH · Annals of the New York Academy of Sciences · 2007
Animal study (in vivo) · mouse · 1 result
- Activation of tumor-associated macrophages by thymosin alpha 1.
Shrivastava P · International journal of immunopathology and pharmacology · 2004
Animal study (in vivo) · mouse · 11 results
- Immunopotentiator Thymosin Alpha-1 Promotes Neurogenesis and Cognition in the Developing Mouse via a Systemic Th1 Bias.
Wang G · Neuroscience bulletin · 2017
Animal study (in vivo) · mouse · 11 results
- Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
Mastino A · Cellular immunology · 1991
Animal study (in vivo) · mouse · 4 results
- Thymosin alpha 1 protects liver and aorta from oxidative damage in atherosclerotic rabbits.
Gökkusu C · Life sciences · 1996
Animal study (in vivo) · rabbit · 3 results
- Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
Shao C · International immunopharmacology · 2013
Animal study (in vivo) · mouse · 8 results
- Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris.
Chen JH · Cancer immunology, immunotherapy : CII · 2010
Animal study (in vivo) · mouse · 9 results
- A role of the thymus and thymosin-alpha1 in brain NGF levels and NGF receptor expression.
Turrini P · Journal of neuroimmunology · 1998
Animal study (in vivo) · rat · 2 results
- Thymosin alpha 1 exerts protective effect against the 5-FU induced bone marrow toxicity.
Ohta Y · International journal of immunopharmacology · 1985
Animal study (in vivo) · mouse · 5 results
- Modulation of endogenous prostaglandins by thymosin-alpha 1 in lymphocytes.
Rinaldi-Garaci C · Cellular immunology · 1983
Animal study (in vivo) · mouse · 7 results